Series 3 Episode 5. Andrew Lotery And Amanda Stride: Glucokinase MODY – A Mildly Raised Fasting Glucose For Life That Should Not Be Treated One In Six Billion podcast

A tartalmat a Andrew Hattersley and Maggie Shepherd, Andrew Hattersley, and Maggie Shepherd biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a Andrew Hattersley and Maggie Shepherd, Andrew Hattersley, and Maggie Shepherd vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.

One in Six Billion »
Series 3 episode 5. Andrew Lotery and Amanda Stride: Glucokinase MODY – a mildly raised fasting glucose for life that should not be treated

4d ago 32:38

Megosztás

MP3•Epizód kép

Send us a text

In this episode we talk to Andrew Lotery about how he was found to have a raised fasting glucose on an insurance medical. He was treated as Type 2 diabetes but he questioned this as he was young. slim and physically fit. A chance reading of a research funder’s newsletter led him to the Exeter team and a diagnosis of glucokinase MODY.
Amanda Stride worked as a research registrar in Exeter. She showed that in glucokinase MODY the fasting glucose was raised from birth and remained stable and regulated throughout life with treatment not changing the blood glucose.
Anna Steele showed in her PhD that patients with glucokinase MODY did not get complications affecting the eye or kidney even after 50 years of raised glucose. So in glucokinase MODY treatment with insulin or tablets is not needed and does not work; patients should be discharged and not followed up.

28 epizódok

#Fitness #Andrew Hattersley And Maggie Shepherd #Andrew Hattersley #Maggie Shepherd #Medicine